Insider Selling: Aditxt (NASDAQ:ADTX) Major Shareholder Sells 735,462 Shares of Stock

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt sold 735,462 shares of Aditxt stock in a transaction on Friday, June 5th. The stock was sold at an average price of $0.06, for a total transaction of $44,127.72. Following the transaction, the insider directly owned 505,302 shares in the company, valued at $30,318.12. This represents a 59.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Thursday, June 4th, Financial Lp Hrt acquired 843,622 shares of Aditxt stock. The shares were purchased at an average cost of $0.08 per share, for a total transaction of $67,489.76.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The stock was sold at an average price of $7.56, for a total transaction of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The stock was sold at an average price of $7.83, for a total transaction of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt acquired 2,700 shares of Aditxt stock. The stock was purchased at an average price of $8.91 per share, with a total value of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total transaction of $3,588.30.

Aditxt Trading Down 19.6%

Shares of ADTX stock traded down $0.01 during trading on Monday, hitting $0.05. The company’s stock had a trading volume of 34,601,770 shares, compared to its average volume of 2,810,720. The company has a market cap of $40,718.40, a PE ratio of 0.00 and a beta of 0.84. The business has a fifty day moving average of $7.80 and a 200-day moving average of $170.33. Aditxt, Inc. has a 52 week low of $0.05 and a 52 week high of $53,451.08.

Aditxt (NASDAQ:ADTX) last issued its quarterly earnings results on Tuesday, March 31st. The company reported $315,563.31 EPS for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on ADTX shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. Wall Street Zen upgraded shares of Aditxt to a “sell” rating in a report on Saturday, May 23rd. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.